查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888612

全球標靶DNA和RNA定序市場：市場規模、佔有率和趨勢分析（按工作流程、技術、應用、類型、最終用途和地區分類），細分市場預測（2025-2033年）

Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Workflow (Pre-sequencing, Sequencing, Data Analysis), By Technology, By Application, By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

標靶DNA和RNA定序市場概覽

全球標靶DNA和RNA定序市場預計在2024年達到74億美元，預計2033年將達到345.6億美元。

預計從 2025 年到 2033 年，該市場將以 18.98% 的複合年成長率成長。由於精準醫療的日益普及、癌症和遺傳疾病發病率的上升，以及對更具成本效益和高度精確的測序方法的需求（這些方法能夠對特定基因和基因組區域進行深入分析），該市場正在快速成長。

對精準診斷和標靶治療的需求日益成長

癌症、心臟病和遺傳性疾病等疾病發生率的上升，推動了對疾病診斷和特異性治療方法的需求，進而促進了市場成長。標靶定序能夠更早識別致病突變，從而有助於診斷並改善治療方案。這對於可採用標靶治療治療的癌症類型尤其重要，因為標靶療法的副作用可能比化療少。

此外，標靶定序正在推動向個人化、微創治療的轉型，尤其是在腫瘤學和罕見疾病領域。識別可操作的基因改變使臨床醫生能夠選擇比標準化療或廣譜治療更有效、毒性更小的標靶治療。實現個人化醫療、最大限度降低毒性並改善患者預後的能力，持續推動著標靶定序在臨床、研究和製藥領域的應用，並成為醫學創新和市場擴張的重要推動力。

技術進步和成本效益的提高將加速其普及應用。

新一代定序平台、富集化學和自動化技術的進步，使得標靶定序速度更快、更準確、成本顯著降低。改良的捕獲試劑盒、高通量系統和高性能試劑等創新技術，縮短了處理時間和周轉時間，從而支持了醫院、研究實驗室和生物技術公司等機構的應用。

此外，標靶定序僅針對特定基因區域，能夠提供更深的覆蓋度和更高的靈敏度，從而檢測出罕見變異，其性能優於全基因組定序。由於數據分析要求更低、儲存需求更少、工作流程更經濟高效，靶向測序正日益被醫療機構應用於常規診斷、精準醫療和大規模基因組學計畫等領域。這種基於效率的價值提案持續推動市場擴張。

目錄

第1章 分析方法和範圍

第2章執行摘要

3. 標靶DNA和RNA定序市場：促進因素、趨勢和範圍

  • 市場概覽/關係展望
  • 市場規模和成長率預測
  • 市場動態
  • 商業環境分析
    • PESTLE分析
    • 波特五力分析

第4章：靶向DNA和RNA測序市場：按技術分類的估算和趨勢分析

  • 標靶DNA和RNA定序市場：按技術分類的變異分析（2023年和2033年）
  • 下一代定序（NGS）
  • 其他

第5章 標靶DNA和RNA定序市場：依工作流程分類的估算與趨勢分析

  • 按變異分析和工作流程分類的標靶DNA和RNA定序市場（2023年和2033年）
  • 前序
  • 順序
  • 數據分析

第6章：靶向DNA和RNA測序市場：按應用分類的估計和趨勢分析

  • 標靶DNA和RNA定序市場：按應用領域分類的變化分析（2023年和2033年）
  • 人類生物醫學研究
  • 植物和動物科學
  • 藥物發現
  • 其他

第7章：標靶DNA和RNA定序市場：按類型分類的估計和趨勢分析

  • 標靶DNA和RNA定序市場：按類型分類的變化分析（2023年和2033年）
  • 基於DNA的標靶定序
  • 基於RNA的標靶定序

8. 標靶DNA和RNA定序市場：依最終用途分類的估算與趨勢分析

  • 按變異分析和最終用途分類的標靶DNA和RNA定序市場（2023年和2033年）
  • 學術與研究
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他

9. 標靶DNA和RNA定序市場：區域估算與趨勢分析

  • 標靶DNA和RNA定序市場：按地區分類的市場佔有率（百萬美元，2024年和2033年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲標靶DNA和RNA定序市場（2021-2033年）
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區標靶DNA和RNA定序市場（2021-2033年）
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲標靶DNA和RNA定序市場（2021-2033年）
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲標靶DNA和RNA定序市場（2021-2033年）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 公司分類
  • 策略規劃
  • 企業市場分析（2024）
  • 公司簡介/列表
    • Illumina
    • F. Hoffman-La Roche Ltd.
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Oxford Nanopore Technologies
    • PierianDx
    • Genomatix GmbH
    • DNASTAR, Inc.
    • Perkin Elmer, Inc.
Product Code: GVR-1-68038-681-3

Targeted DNA RNA Sequencing Market Summary

The global targeted DNA RNA sequencing market size was estimated at USD 7.40 billion in 2024 and is projected to reach USD 34.56 billion by 2033, expanding at a CAGR of 18.98% from 2025 to 2033. The market is growing rapidly due to the increasing use of precision medicine, the rising incidence of cancer and genetic diseases, and the demand for more cost-efficient and highly accurate sequencing methodologies that enable the deep analysis of specific genes or genomic regions.

Growing Demand for Precision Diagnostics and Targeted Therapies

With the rising incidences of diseases such as cancer, heart diseases, and genetic disorders, the need to diagnose and develop specific treatments drives the market growth. In targeted sequencing, it is possible to identify pathogenic variations at an earlier stage in the process, which facilitates diagnosis and improves treatment options. This is particularly sensitive if the cancer type can be treated with targeted therapy that may not cause as many side effects as chemotherapy.

Moreover, targeted sequencing facilitates the transition to personalized, less invasive therapies, particularly in the fields of oncology and rare disease. By identifying actionable genetic mutations, clinicians can select targeted therapies that are both more effective and have lower toxicity compared to standard chemotherapy or broad-spectrum treatments. The capacity for individualized care, minimal toxicity, and improved patient outcomes continues to drive the use of targeted sequencing in the clinical, research, and pharmaceutical sectors, making it a major contributor to healthcare innovation and market expansion.

Technological Advancements and Cost Efficiency Accelerating Adoption

Advances in next-generation sequencing platforms, enrichment chemistry, and automation make targeted sequencing faster, more accurate, and significantly less costly. Innovations such as improved capture kits, high-throughput systems, and enhanced reagents are reducing processing and turnaround times, thereby supporting applications in hospitals, research laboratories, and biotech companies.

Moreover, targeted sequencing focuses on only selected gene regions, allowing for deeper coverage and increased sensitivity in detecting rarer variants, which is superior to whole-genome sequencing. Given that targeted sequencing has lower data analysis requirements, fewer storage needs, and cost-efficient workflows, it is increasingly chosen by healthcare providers in areas such as routine diagnostics, precision medicine, and large genomic programs. This value proposition, based on efficiencies, continues to drive market expansion.

Global Targeted DNA RNA Sequencing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global targeted DNA RNA sequencing market based on technology, workflow, application, type, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • NGS
    • Method
    • Exome Sequencing
    • Enrichment Sequencing
    • Amplicon Sequencing
    • Others
    • Application
    • Cancer Gene Sequencing
    • Inherited Disease Screening
    • Drug Development
    • Forensic Genomics
    • 16S ribosomal RNA (rRNA) sequencing
  • Others
  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Pre-sequencing
  • Sequencing
  • Data Analysis
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Human Biomedical Research
  • Plant & Animal Sciences
  • Drug Discovery
  • Others
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • DNA Based Targeted Sequencing
  • RNA Based Targeted Sequencing
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Technology
    • 1.2.2. Workflow
    • 1.2.3. Application
    • 1.2.4. Type
    • 1.2.5. End Use
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Targeted DNA RNA Sequencing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Growing Demand for Precision Diagnostics and Targeted Therapies
      • 3.3.1.2. Technological Advancements and Cost Efficiency Accelerating Adoption
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. High Initial Capital Investment
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Targeted DNA RNA Sequencing Market: Technology Estimates & Trend Analysis

  • 4.1. Technology Segment Dashboard
  • 4.2. Targeted DNA RNA Sequencing Market: Technology Movement Analysis, USD Million, 2023 & 2033
  • 4.3. NGS
    • 4.3.1. NGS Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Method Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.1. Exome Sequencing
        • 4.3.2.1.1. Exome Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2. Enrichment Sequencing
        • 4.3.2.2.1. Enrichment Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3. Amplicon Sequencing
        • 4.3.2.3.1. Amplicon Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.4. Others
        • 4.3.2.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Application Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.1. Cancer Gene Sequencing
        • 4.3.3.1.1. Cancer Gene Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2. Inherited Disease Screening
        • 4.3.3.2.1. Inherited Disease Screening Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3. Drug Development
        • 4.3.3.3.1. Drug Development Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.4. Forensic Genomics
        • 4.3.3.4.1. Forensic Genomics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.5. 16S Ribosomal RNA (rRNA)
        • 4.3.3.5.1. 16S Ribosomal RNA (rRNA) Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Targeted DNA RNA Sequencing Market: Workflow Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Targeted DNA RNA Sequencing Market: Workflow Movement Analysis, USD Million, 2023 & 2033
  • 5.3. Pre-sequencing
    • 5.3.1. Pre-sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Sequencing
    • 5.4.1. Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Data Analysis
    • 5.5.1. Data Analysis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Targeted DNA RNA Sequencing Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Targeted DNA RNA Sequencing Market: Application Movement Analysis, USD Million, 2023 & 2033
  • 6.3. Human Biomedical Research
    • 6.3.1. Human Biomedical Research Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Plant & Animal Sciences
    • 6.4.1. Plant & Animal Sciences Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Drug Discovery
    • 6.5.1. Drug Discovery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Targeted DNA RNA Sequencing Market: Type Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Targeted DNA RNA Sequencing Market: Type Movement Analysis, USD Million, 2023 & 2033
  • 7.3. DNA Based Targeted Sequencing
    • 7.3.1. DNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. RNA Based Targeted Sequencing
    • 7.4.1. RNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Targeted DNA RNA Sequencing Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Targeted DNA RNA Sequencing Market: End Use Movement Analysis, USD Million, 2023 & 2033
  • 8.3. Academic Research
    • 8.3.1. Academic Research Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Hospitals & Clinics
    • 8.4.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Pharma & Biotech Entities
    • 8.5.1. Pharma & Biotech Entities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Targeted DNA RNA Sequencing Market: Regional Estimates & Trend Analysis

  • 9.1. Targeted DNA RNA Sequencing Market Share, By Region, 2024 & 2033, USD Million
  • 9.2. North America
    • 9.2.1. North America Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Competitive Scenario
      • 9.2.2.3. Regulatory Framework
      • 9.2.2.4. U.S. targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Competitive Scenario
      • 9.2.3.3. Regulatory Framework
      • 9.2.3.4. Canada targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Competitive Scenario
      • 9.2.4.3. Regulatory Framework
      • 9.2.4.4. Mexico targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. UK targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Germany targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. France targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Competitive Scenario
      • 9.3.5.3. Regulatory Framework
      • 9.3.5.4. Italy targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Competitive Scenario
      • 9.3.6.3. Regulatory Framework
      • 9.3.6.4. Spain targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Competitive Scenario
      • 9.3.7.3. Regulatory Framework
      • 9.3.7.4. Denmark targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Competitive Scenario
      • 9.3.8.3. Regulatory Framework
      • 9.3.8.4. Sweden targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Competitive Scenario
      • 9.3.9.3. Regulatory Framework
      • 9.3.9.4. Norway targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. Japan targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. China targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. India targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Australia targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.4.6. Thailand
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Thailand targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.4.7. South Korea
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. South Korea targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Brazil targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. Argentina targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. South Africa targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Saudi Arabia targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competitive Scenario
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. UAE targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Competitive Scenario
      • 9.6.5.3. Regulatory Framework
      • 9.6.5.4. Kuwait targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. Illumina
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. F. Hoffman-La Roche Ltd.
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. QIAGEN
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Thermo Fisher Scientific, Inc.
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. Bio-Rad Laboratories, Inc.
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Oxford Nanopore Technologies
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. PierianDx
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. Genomatix GmbH
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. DNASTAR, Inc.
      • 10.4.9.1. Participant's Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Perkin Elmer, Inc.
      • 10.4.10.1. Participant's Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 4. Global Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 5. Global Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 6. Global Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 7. Global Targeted DNA RNA Sequencing Market, End Use, 2021 - 2033 (USD Million)
  • Table 8. Global Targeted DNA RNA Sequencing Market, by Region, 2021 - 2033 (USD Million)
  • Table 9. North America Targeted DNA RNA Sequencing Market, by Country, 2021 - 2033 (USD Million)
  • Table 10. North America Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 11. North America Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 12. North America Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 13. North America Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 14. North America Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 15. U.S. Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 16. U.S. Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 17. U.S. Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 18. U.S. Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 19. U.S. Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 20. Canada Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 21. Canada Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 22. Canada Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 23. Canada Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 24. Canada Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 25. Mexico Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 26. Mexico Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 27. Mexico Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 28. Mexico Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 29. Mexico Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 30. Europe Targeted DNA RNA Sequencing Market, by Country, 2021 - 2033 (USD Million)
  • Table 31. Europe Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 32. Europe Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 33. Europe Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 34. Europe Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 35. Europe Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 36. Germany Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 37. Germany Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 38. Germany Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 39. Germany Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 40. Germany Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 41. UK Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 42. UK Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 43. UK Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 44. UK Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 45. UK Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 46. France Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 47. France Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 48. France Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 49. France Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 50. France Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 51. Italy Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 52. Italy Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 53. Italy Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 54. Italy Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 55. Italy Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 56. Spain Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 57. Spain Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 58. Spain Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 59. Spain Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 60. Spain Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61. Denmark Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 62. Denmark Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 63. Denmark Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 64. Denmark Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 65. Denmark Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 66. Norway Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 67. Norway Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 68. Norway Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 69. Norway Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 70. Norway Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 71. Sweden Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 72. Sweden Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 73. Sweden Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 74. Sweden Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 75. Sweden Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 76. Asia Pacific Targeted DNA RNA Sequencing Market, by Country, 2021 - 2033 (USD Million)
  • Table 77. Asia Pacific Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 78. Asia Pacific Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 79. Asia Pacific Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 80. Asia Pacific Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 81. Asia Pacific Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 82. China Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 83. China Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 84. China Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 85. China Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 86. China Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87. Japan Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 88. Japan Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 89. Japan Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 90. Japan Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 91. Japan Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 92. India Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 93. India Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 94. India Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 95. India Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 96. India Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 97. South Korea Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 98. South Korea Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 99. South Korea Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 100. South Korea Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 101. South Korea Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 102. Australia Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 103. Australia Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 104. Australia Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 105. Australia Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 106. Australia Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 107. Thailand Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 108. Thailand Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 109. Thailand Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 110. Thailand Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 111. Thailand Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 112. Latin America Targeted DNA RNA Sequencing Market, by Country, 2021 - 2033 (USD Million)
  • Table 113. Latin America Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 114. Latin America Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 115. Latin America Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 116. Latin America Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 117. Latin America Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 118. Brazil Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 119. Brazil Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 120. Brazil Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 121. Brazil Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 122. Brazil Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 123. Argentina Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 124. Argentina Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 125. Argentina Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 126. Argentina Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 127. Argentina Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 128. Middle East and Africa Targeted DNA RNA Sequencing Market, by Country, 2021 - 2033 (USD Million)
  • Table 129. Middle East and Africa Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 130. Middle East and Africa Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 131. Middle East and Africa Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 132. Middle East and Africa Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 133. Middle East and Africa Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 134. South Africa Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 135. South Africa Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 136. South Africa Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 137. South Africa Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 138. South Africa Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 139. Saudi Arabia Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 140. Saudi Arabia Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 141. Saudi Arabia Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 142. Saudi Arabia Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 143. Saudi Arabia Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 144. UAE Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 145. UAE Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 146. UAE Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 147. UAE Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 148. UAE Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 149. Kuwait Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 150. Kuwait Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 151. Kuwait Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 152. Kuwait Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 153. Kuwait Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Targeted DNA RNA sequencing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validation & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 Targeted DNA RNA sequencing market: Technology outlook key takeaways
  • Fig. 19 Targeted DNA RNA sequencing market: Technology movement analysis
  • Fig. 20 NGS, 2021 - 2033 (USD Million)
  • Fig. 21 Exome sequencing, 2021 - 2033 (USD Million)
  • Fig. 22 Enrichment sequencing, 2021 - 2033 (USD Million)
  • Fig. 23 Amplicon sequencing, 2021 - 2033 (USD Million)
  • Fig. 24 Others, 2021 - 2033 (USD Million)
  • Fig. 25 Cancer gene sequencing, 2021 - 2033 (USD Million)
  • Fig. 26 Inherited disease screening, 2021 - 2033 (USD Million)
  • Fig. 27 Drug development, 2021 - 2033 (USD Million)
  • Fig. 28 Forensic genomics, 2021 - 2033 (USD Million)
  • Fig. 29 16S ribosomal RNA (rRNA) sequencing, 2021 - 2033 (USD Million)
  • Fig. 30 Others, 2021 - 2033 (USD Million)
  • Fig. 31 Targeted DNA RNA sequencing market: Workflow outlook key takeaways
  • Fig. 32 Targeted DNA RNA sequencing market: Workflow movement analysis
  • Fig. 33 Pre-sequencing, 2021 - 2033 (USD Million)
  • Fig. 34 Sequencing, 2021 - 2033 (USD Million)
  • Fig. 35 Data Analysis, 2021 - 2033 (USD Million)
  • Fig. 36 Targeted DNA RNA sequencing market: Application outlook key takeaways
  • Fig. 37 Targeted DNA RNA sequencing market: Application movement analysis
  • Fig. 38 Human Biomedical Research, 2021 - 2033 (USD Million)
  • Fig. 39 Plant & Animal Sciences, 2021 - 2033 (USD Million)
  • Fig. 40 Drug Discovery, 2021 - 2033 (USD Million)
  • Fig. 41 Others, 2021 - 2033 (USD Million)
  • Fig. 42 Targeted DNA RNA sequencing market: Type outlook key takeaways
  • Fig. 43 Targeted DNA RNA sequencing market: Type movement analysis
  • Fig. 44 DNA Based Targeted Sequencing, 2021 - 2033 (USD Million)
  • Fig. 45 RNA Based Targeted Sequencing, 2021 - 2033 (USD Million)
  • Fig. 46 Targeted DNA RNA sequencing market: End use outlook key takeaways
  • Fig. 47 Targeted DNA RNA sequencing market: End use movement analysis
  • Fig. 48 Academic Research, 2021 - 2033 (USD Million)
  • Fig. 49 Hospitals & Clinics, 2021 - 2033 (USD Million)
  • Fig. 50 Pharma & Biotech Entities, 2021 - 2033 (USD Million)
  • Fig. 51 Other Users, 2021 - 2033 (USD Million)
  • Fig. 52 Regional marketplace outlook, 2024 & 2033, (USD Million)
  • Fig. 53 Regional marketplace: Key takeaways
  • Fig. 54 North America targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 U.S. targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Canada targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Mexico targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Europe targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Germany targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 UK targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 France targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Italy targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Spain targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Denmark targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Sweden targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Norway targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 78 Asia Pacific targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Japan targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 China targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 India targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 South Korea targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Australia targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Thailand targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Latin America targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Brazil targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Argentina targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 MEA targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 South Africa targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Saudi Arabia targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 UAE targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Kuwait targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 Market position analysis
  • Fig. 106 Market participant categorization
  • Fig. 107 Strategic framework